Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
Chinese Researchers Finds New Potential Asthma Treatment 2/8/2018
BeiGene Announces Commercial Availability of VIDAZA (Azacitidine ... 2/6/2018
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tisl... 1/31/2018
Lee's Subsidiary Granted Clinical Trial Approval in Three Separat... 1/31/2018
Galectin Granted Two Chinese Patents for Lead Cirrhosis/Fibrosis ... 1/25/2018
Chinese and American Scientists Find New Approach to Develop Flu ... 1/19/2018
Page:4/4    Total number of articles:96  :[1][2][3][4]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links